Article
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.
Molecular and cellular biochemistry - 1 Feb 2009
Polgar Orsolya, Deeken John F, Ediriwickrema Lilangi S, Tamaki Akina, Steinberg Seth M, Robey Robert W, Bates Susan E
Abstract excerpt
ABCG2 is a half-transporter initially described in multidrug-resistant cancer cells and lately identified as an important factor in the pharmacokinetics of its substrates. Q141K is by far the most intensively studied single nucleotide polymorphism of ABCG2 with potential clinical relevance. Here...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
